Balyasny Asset Management
DMK

Balyasny Asset Management’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Balyasny Asset Management’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-23,179
Closed -$1.78M – 2643
2021
Q2 		$1.78M Buy
+23,179
New +$1.41M 0.01% 1059
2018
Q1 		– Sell
-3,157
Closed -$972K – 2424
2017
Q4 		$972K Buy
3,157
+300
+11% +$98.7K ﹤0.01% 1344
2017
Q3 		$1.04M Buy
+2,857
New +$1.01M ﹤0.01% 1152

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VCA
Verdence Capital Advisors Hunt Valley, Maryland $1.71B AUM 24.88% 1-Year Est. Return